PMC:2778502 / 29427-29918 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/2778502","sourcedb":"PMC","sourceid":"2778502","source_url":"http://www.ncbi.nlm.nih.gov/pmc/2778502","text":"18. Polycythemia\nPolycythemia may be primary (polycythemia vera) or secondary to smoking, chronic hypoxia, certain tumors, or drugs. Drug-induced polycythemia can be seen with excess use of rHuEPO or anabolic steroids. Abuse of both types of agents by athletes may be associated with increased thrombotic risk [84]. Use of diuretics with volume contraction can contribute to pseudopolycythemia, where the hematocrit is elevated from hemoconcentration but true red cell mass is not increased.","divisions":[{"label":"Title","span":{"begin":0,"end":16}}],"tracks":[{"project":"2_test","denotations":[{"id":"19960059-16799100-1061376","span":{"begin":311,"end":313},"obj":"16799100"}],"attributes":[{"subj":"19960059-16799100-1061376","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"2_test","color":"#93b9ec","default":true}]}]}}